Not All TF Activity Assays Measure Tissue Factor – RPTH Journal
RPTH Journal shared a post on LinkedIn about a recent article by Ana T.A. Sachetto et al, adding:
“Measuring tissue factor activity in plasma sounds straightforward.
In reality, it’s anything but!
TF-positive extracellular vesicles are increasingly linked to thrombosis, cancer, sepsis, and inflammatory disease, but accurately detecting low circulating TF activity remains a major technical challenge.
A new RPTH methodological study systematically evaluated 3 commercial plasma TF activity assays against the well-established Chapel Hill EV TF activity assay.
What did they find?
All 3 kits detected recombinant TF (Innovin)
- But sensitivity and specificity varied substantially
- Plasma background absorbance and hemolysis interfered with measurements
- Some assays detected large amounts of TF-independent activity
- Plasma clotting occurred in certain assay systems
The strongest performer?
The Chapel Hill EV TF activity assay remained the most sensitive and specific approach for detecting TF-dependent activity.
Compared with commercial assays, fold increase in LPS-stimulated samples vs controls:
- Chapel Hill assay: 33-fold
- Abcam: 11-fold
- AssaySense: 5-fold
One important message from this paper:
Not all ‘TF activity’ measurements actually reflect tissue factor. Without proper controls, plasma background, EV-independent coagulation activity, and optical interference can all distort interpretation.
A valuable technical contribution for anyone studying extracellular vesicles, coagulation, immunothrombosis, or plasma biomarkers.”
Title: Evaluation of 3 commercial assays for the measurement of tissue factor activity in human plasma
Authors: Ana T.A. Sachetto, Dougald M. Monroe, Nigel Mackman
Other articles about RPTH Journal on Hemostasis Today.
-
May 8, 2026, 18:48Carlos Penalillo Pimentel: Detection of Rare Blood Donor Phenotypes During Investigation of Serologic Discrepancies
-
May 8, 2026, 18:23How SCD Affects Daily Life in sub-Saharan Africa? – American Society of Hematology
-
May 8, 2026, 18:03Risk of Thrombosis After Stopping Anticoagulation in APS With aPL Negativization -JTH
-
May 8, 2026, 17:35Gurpreet Kaur Sagoo: A Rare Bone Marrow Failure Syndrome That Challenges Early Diagnosis
-
May 8, 2026, 17:31Edward Lee Carter։ Stroke Prevention Starts in the Emergency Department – but Doesn’t End There
-
May 8, 2026, 17:14Hayder Kadhim: Determinants and Outcomes of OAC Discontinuation in Atrial Fibrillation
-
May 8, 2026, 17:11Drazen Perkov: Complication Management in Endovascular Thrombectomy
-
May 8, 2026, 17:07Basel Saber: New Evidence on Stroke Prevention in Post-Operative Atrial Fibrillation
-
May 8, 2026, 17:00Adriana Skafi: Case Report on Catastrophic Antiphospholipid Syndrome